A detailed history of Ferguson Wellman Capital Management, Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Ferguson Wellman Capital Management, Inc holds 292,735 shares of JNJ stock, worth $45.2 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares
292,735
Previous 268,123 9.18%
Holding current value
$45.2 Million
Previous $43.5 Million 9.18%
% of portfolio
0.95%
Previous 0.95%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$145.48 - $167.38 $3.58 Million - $4.12 Million
24,612 Added 9.18%
292,735 $47.4 Million
Q3 2024

Oct 18, 2024

SELL
$145.48 - $167.38 $41.5 Million - $47.8 Million
-285,528 Reduced 51.57%
268,123 $43.5 Million
Q2 2024

Jul 16, 2024

SELL
$144.38 - $157.78 $2.17 Million - $2.38 Million
-15,057 Reduced 2.65%
553,651 $80.9 Million
Q1 2024

Apr 09, 2024

BUY
$155.22 - $162.74 $325,185 - $340,940
2,095 Added 0.37%
568,708 $90 Million
Q4 2023

Jan 11, 2024

BUY
$145.6 - $158.88 $1.12 Million - $1.22 Million
7,697 Added 1.38%
566,613 $88.8 Million
Q3 2023

Oct 12, 2023

SELL
$155.75 - $174.48 $336,731 - $377,225
-2,162 Reduced 0.39%
558,916 $87.1 Million
Q2 2023

Jul 11, 2023

BUY
$154.35 - $166.11 $813,270 - $875,233
5,269 Added 0.95%
561,078 $92.9 Million
Q1 2023

Apr 20, 2023

BUY
$151.05 - $180.26 $1.09 Million - $1.3 Million
7,199 Added 1.31%
555,809 $86.2 Million
Q4 2022

Jan 13, 2023

BUY
$160.2 - $179.79 $42.7 Million - $47.9 Million
266,623 Added 94.55%
548,610 $96.9 Million
Q3 2022

Oct 17, 2022

SELL
$161.33 - $179.52 $1.52 Million - $1.69 Million
-9,419 Reduced 3.23%
281,987 $46.1 Million
Q2 2022

Jul 14, 2022

BUY
$168.19 - $186.01 $109,828 - $121,464
653 Added 0.22%
291,406 $51.7 Million
Q1 2022

Apr 14, 2022

SELL
$158.14 - $179.59 $57,562 - $65,370
-364 Reduced 0.13%
290,753 $51.5 Million
Q4 2021

Jan 10, 2022

SELL
$155.93 - $173.01 $538,426 - $597,403
-3,453 Reduced 1.17%
291,117 $49.8 Million
Q3 2021

Oct 22, 2021

SELL
$161.5 - $179.47 $15.5 Million - $17.2 Million
-96,083 Reduced 24.6%
294,570 $47.6 Million
Q2 2021

Jul 12, 2021

BUY
$159.48 - $171.07 $1.23 Million - $1.32 Million
7,689 Added 2.01%
390,653 $64.4 Million
Q1 2021

Apr 26, 2021

SELL
$153.07 - $170.48 $1.2 Million - $1.34 Million
-7,834 Reduced 2.0%
382,964 $62.9 Million
Q4 2020

Feb 04, 2021

BUY
$137.11 - $157.38 $5.18 Million - $5.95 Million
37,807 Added 10.71%
390,798 $61.5 Million
Q3 2020

Oct 13, 2020

BUY
$140.38 - $153.83 $1.89 Million - $2.07 Million
13,433 Added 3.96%
352,991 $52.6 Million
Q2 2020

Aug 04, 2020

BUY
$128.81 - $155.51 $302,188 - $364,826
2,346 Added 0.7%
339,558 $47.8 Million
Q1 2020

Apr 21, 2020

BUY
$111.14 - $153.99 $7.78 Million - $10.8 Million
70,041 Added 26.22%
337,212 $44.2 Million
Q4 2019

Jan 24, 2020

SELL
$127.5 - $146.44 $191,377 - $219,806
-1,501 Reduced 0.56%
267,171 $39 Million
Q3 2019

Oct 15, 2019

BUY
$126.95 - $142.14 $1.04 Million - $1.16 Million
8,175 Added 3.14%
268,672 $34.8 Million
Q2 2019

Jul 16, 2019

SELL
$131.15 - $144.24 $10.5 Million - $11.6 Million
-80,107 Reduced 23.52%
260,497 $36.3 Million
Q1 2019

Apr 11, 2019

BUY
$125.72 - $139.79 $4.22 Million - $4.69 Million
33,532 Added 10.92%
340,604 $47.6 Million
Q4 2018

Jan 16, 2019

BUY
$122.84 - $147.84 $14 Million - $16.8 Million
113,689 Added 58.79%
307,072 $39.6 Million
Q3 2018

Oct 25, 2018

BUY
$121.58 - $142.88 $10.9 Million - $12.8 Million
89,384 Added 85.95%
193,383 $26.7 Million
Q2 2018

Aug 10, 2018

SELL
$119.4 - $131.76 $5.07 Million - $5.6 Million
-42,489 Reduced 29.01%
103,999 $12.6 Million
Q1 2018

Apr 09, 2018

SELL
$125.1 - $148.14 $5.22 Million - $6.18 Million
-41,742 Reduced 22.18%
146,488 $18.8 Million
Q4 2017

Jan 24, 2018

BUY
$131.22 - $143.62 $48,157 - $52,708
367 Added 0.2%
188,230 $26.3 Million
Q3 2017

Oct 11, 2017

BUY
$129.47 - $135.38 $24.3 Million - $25.4 Million
187,863
187,863 $24.4 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Ferguson Wellman Capital Management, Inc Portfolio

Follow Ferguson Wellman Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ferguson Wellman Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ferguson Wellman Capital Management, Inc with notifications on news.